Leuprolide Active Not Recruiting Phase 2 Trials for High Risk Prostate Cancer / Adenocarcinoma, Prostate / Prostate Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02268175Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate